Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation.

@article{Sarafoff2013TripleTW,
  title={Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation.},
  author={Nikolaus Ivo Sarafoff and Amadea M. Martischnig and Jill Wealer and Katharina Mayer and Julinda Mehilli and Dirk Sibbing and Adnan Kastrati},
  journal={Journal of the American College of Cardiology},
  year={2013},
  volume={61 20},
  pages={2060-6}
}
OBJECTIVES This study sought to evaluate whether prasugrel may serve as an alternative to clopidogrel in patients with triple therapy. BACKGROUND Approximately 10% of patients who receive dual antiplatelet therapy after percutaneous coronary intervention have an indication for oral anticoagulation and are thus treated with triple therapy. The standard adenosine diphosphate receptor blocker in this setting is clopidogrel. Data regarding prasugrel as part of triple therapy are not available… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 6 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 68 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 33 references

The WOEST Trial: First randomised trial comparing two regimens with and without aspirin in patients on oral anticoagulant therapy undergoing coronary stenting

  • TO WillemDewilde, Freek Verheugt, +15 authors Jurriën ten Berg
  • ESC Congress. Munich,
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…